Search
for

    Glossary Metastatic Melanoma

    advanced skin cancer spread to other body parts

    Metastatic melanoma, also known as Stage IV melanoma, is an advanced form of skin cancer where the melanoma cells have spread from the original tumor site to other parts of the body, such as the lungs, liver, brain, or bones. This stage of melanoma is particularly challenging to treat and often requires a combination of therapies, including surgery, immunotherapy, targeted therapy, and radiation.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Hair and nail adverse events during treatment with target therapies for metastatic melanoma Journal of The American Academy of Dermatology · 2016
    2. Metastatic Melanoma of the Tongue: A Rare Case Actas Dermo-Sifiliográficas · 2012
    3. Metastasis of an Untreated Thin Melanoma in a Very Elderly Patient International Journal of Dermatology · 1990 · 1 citations
    4. 644 Tumor cell adhesion as a risk factor for SLN metastasis and predictor of disease recurrence in primary cutaneous melanoma Journal of Investigative Dermatology · 2016
    5. Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis Acta neuropathologica communications · 2019 · 29 citations
    6. Predictors of sentinel lymph node metastasis in melanoma Yearbook of Dermatology and Dermatologic Surgery · 2011
    7. Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma JAAD case reports · 2023 · 1 citations
    8. Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients. Journal of the European Academy of Dermatology and Venereology · 2014 · 31 citations
    9. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma 2016 · 32 citations
    10. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma British Journal of Dermatology · 2012 · 173 citations
    11. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    12. Malignant Melanoma and Its Stromal Nonimmune Microecosystem Journal of Oncology · 2012 · 10 citations
    13. Scalp melanoma after antihair loss mesotherapy Journal of the European Academy of Dermatology and Venereology · 2017 · 6 citations
    14. The Comparison of In Vitro Photosensitizing Efficacy of Curcumin-Loaded Liposomes Following Photodynamic Therapy on Melanoma MUG-Mel2, Squamous Cell Carcinoma SCC-25, and Normal Keratinocyte HaCaT Cells Pharmaceuticals · 2021 · 48 citations
    15. Desmoplastic melanoma presenting as primary alopecia neoplastica: a report of two cases Journal of Cutaneous Pathology · 2016 · 8 citations
    16. 646 SOX4 is essential for melanoma tumorigenesis Journal of Investigative Dermatology · 2016
    17. Molecular mapping of lymph node metastases by real-time reverse transcription polymerase chain reaction in two melanoma patients Journal of Dermatology · 2011
    18. 200 Deep learning model to predict sentinel lymph node status in melanoma patients Journal of Investigative Dermatology · 2023
    19. Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma Frontiers in genetics · 2024
    20. Cutaneous adverse effects of targeted therapies Journal of the American Academy of Dermatology · 2015 · 149 citations
    21. RASopathic alopecia: Hair changes associated with vemurafenib therapy Journal of The American Academy of Dermatology · 2015 · 21 citations
    22. Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib Journal of cutaneous medicine and surgery · 2016 · 10 citations
    23. The Influence of Flightless I: Regeneration versus Wound Healing Journal of Investigative Dermatology · 2011 · 1 citations
    24. Immunotherapy-Induced Scarring Alopecia: A Case Series Skin Appendage Disorders · 2026
    25. Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series Figshare · 2026
    26. Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series Figshare · 2026
    27. Angelica Sinensis and Chinese Arborvitae: A Review on its Phytochemical & Pharmacological Importance International journal of pharmaceutical and bio-medical science (Print) · 2024
    28. Vemurafenib-induced pityriasis amiantacea: a case report Cutaneous and ocular toxicology · 2015 · 9 citations
    29. Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution Cancers · 2024 · 3 citations
    30. ‘Malignant melanoma microecosystem’: Immunohistopathological insights into the stromal cell phenotype Experimental and Therapeutic Medicine · 2011 · 8 citations